Table 2.
Medication class changed to | Olanzapine |
Quetiapine |
Risperidone |
Total |
||||
---|---|---|---|---|---|---|---|---|
N | (%) | N | (%) | N | (%) | N | (%) | |
Another atypical antipsychotica | 30 | (28.9) | 98 | (22.7) | 117 | (31.0) | 245 | (26.8) |
Conventional antipsychoticb | 5 | (4.8) | 21 | (4.9) | 16 | (4.2) | 42 | (4.6) |
Acetylcholinesterase inhibitorc | 14 | (13.5) | 100 | (23.2) | 88 | (23.3) | 202 | (22.1) |
Antidepressants, not tricyclic antidepressantd | 24 | (23.1) | 70 | (16.2) | 59 | (15.6) | 153 | (16.7) |
Tricyclic antidepressant | 0 | (0.0) | 5 | (1.2) | 0 | (0.0) | 5 | (0.6) |
Memantine | 13 | (12.5) | 63 | (14.6) | 38 | (10.1) | 114 | (12.5) |
Antianxiety medicatione | 8 | (7.7) | 41 | (9.5) | 35 | (9.3) | 84 | (9.2) |
Anticonvulsantf | 10 | (9.6) | 34 | (7.9) | 25 | (6.6) | 69 | (7.6) |
Total | 104 | 432 | 378 | 914 |
Includes 40 patients who also added antidepressants, antianxiety, anticholinesterase, anticonvulsant, memantine, conventional antipsychotics, or two atypical antipsychotics.
Includes six patients who also added antidepressant, antianxiety, anticonvulsant, or memantine.
Includes 16 patients who also added memantine.
Includes 12 patients who also added antianxiety, anticholinesterase, anticonvulsant, or memantine.
Includes five patients who also added anticholinesterase or anticonvulsant.
Includes one patient who also added memeatine.